Rank | Keyword | Degree Centrality | Keyword | Betweenness Centrality |
---|---|---|---|---|
1 | STEM CELL | 184 | STEM CELL | 359.39 |
2 | EMBRYONIC STEM CELL | 170 | EMBRYONIC STEM CELL | 267.07 |
3 | REPROGRAMMING | 166 | HUMAN IPSC | 254.20 |
4 | HUMAN IPSC | 162 | REPROGRAMMING | 246.40 |
5 | PLURIPOTENT STEM CELL | 160 | DIFFERENTIATION | 225.41 |
6 | DIFFERENTIATION | 158 | PLURIPOTENT STEM CELL | 221.89 |
7 | REGENERATIVE MEDICINE | 118 | HUMAN EMBRYONIC STEM CELL | 110.40 |
8 | HUMAN EMBRYONIC STEM CELL | 116 | REGENERATIVE MEDICINE | 100.92 |
9 | NEURAL STEM CELL | 116 | MESENCHYMAL STEM CELL | 94.19 |
10 | MESENCHYMAL STEM CELL | 114 | NEURAL STEM CELL | 83.66 |
11 | CELL THERAPY | 102 | TRANSPLANTATION | 70.11 |
12 | PLURIPOTENCY | 102 | PLURIPOTENCY | 67.90 |
13 | TRANSPLANTATION | 102 | CELL THERAPY | 60.74 |
14 | TISSUE ENGINEERING | 98 | CARDIOMYOCYTES | 58.25 |
15 | CARDIOMYOCYTES | 90 | NEURON | 56.58 |
16 | NEURON | 90 | TISSUE ENGINEERING | 54.92 |
17 | DISEASE MODELING | 82 | HIPSC | 43.86 |
18 | HIPSC | 82 | DRUG SCREENING | 42.39 |
19 | PARKINSON’S DISEASE | 82 | GENE EXPRESSION | 40.25 |
20 | GENE EXPRESSION | 80 | DISEASE MODELING | 37.50 |
Rank | Keyword | Degree | Keyword | Betweennes |
---|---|---|---|---|
Centrality | Centrality | |||
1 | METABOLIC ENGINEERING | 100 | METABOLIC ENGINEERING | 378.42 |
2 | YEAST | 90 | GENE EXPRESSION | 312.93 |
3 | GENE CIRCUIT | 82 | YEAST | 286.57 |
4 | ES CELLHERICHIA COLI | 80 | GENE CIRCUIT | 281.48 |
5 | GENE EXPRESSION | 80 | ES CELLHERICHIA COLI | 249.28 |
6 | SACCHAROMYCES CEREVISIAE | 80 | SACCHAROMYCES CEREVISIAE | 229.17 |
7 | PROTEIN ENGINEERING | 66 | SYNTHETIC GENE | 180.28 |
8 | DIRECTED EVOLUTION | 62 | PROTEIN ENGINEERING | 171.01 |
9 | GENE REGULATION | 60 | CELL CYCLE | 169.32 |
10 | SYNTHETIC GENE | 60 | GENE THERAPY | 158.88 |
11 | SYSTEMS BIOLOGY | 60 | TRANSCRIPTION | 146.23 |
12 | TRANSCRIPTION | 60 | DIRECTED EVOLUTION | 143.33 |
13 | GENE ENGINEERING | 56 | SYSTEMS BIOLOGY | 130.95 |
14 | BIOTECHNOLOGY | 50 | GENE REGULATION | 108.56 |
15 | GENE THERAPY | 50 | GENE ENGINEERING | 90.24 |
16 | CRISPR/CAS9 | 48 | ESSENTIAL GENE | 87.67 |
17 | CYANOBACTERIA | 46 | CELL-FREE PROTEIN SYNTHESIS | 76.44 |
18 | ESSENTIAL GENE | 46 | EVOLUTION | 71.90 |
19 | EVOLUTION | 44 | TRANSCRIPTION FACTOR | 70.90 |
20 | E. COLI | 42 | BIOTECHNOLOGY | 66.57 |
Rank | Keyword | Degree Centrality | Keyword | Betweenness Centrality |
---|---|---|---|---|
1 | CRISPR | 188 | CRISPR | 1,378.00 |
2 | GENOME EDITING | 156 | GENOME EDITING | 664.00 |
3 | CRISPR/CAS | 132 | CRISPR/CAS | 441.37 |
4 | GENOME ENGINEERING | 94 | GENOME ENGINEERING | 157.52 |
5 | HOMOLOGOUS RECOMBINATION | 84 | GENES | 135.44 |
6 | GENES | 76 | HOMOLOGOUS RECOMBINATION | 111.44 |
7 | ZEBRAFISH | 70 | ZEBRAFISH | 110.97 |
8 | GENE TARGET | 66 | GENE REGULATION | 60.97 |
9 | TALEN | 64 | CRISPRI | 53.39 |
10 | SYNTHETIC BIOLOGY | 58 | APOPTOSIS | 49.33 |
11 | GENE REGULATION | 56 | DNA REPAIR | 48.34 |
12 | GENE THERAPY | 56 | SYNTHETIC BIOLOGY | 47.97 |
13 | DNA REPAIR | 54 | GENE TARGET | 47.13 |
14 | GENE KNOCKOUT | 54 | IPSC | 42.64 |
15 | IPSC | 50 | GENE KNOCKOUT | 41.15 |
16 | ZFN | 50 | TALEN | 41.09 |
17 | SGRNA | 46 | GENE THERAPY | 39.40 |
18 | CANCER | 42 | EVOLUTION | 37.89 |
19 | CRRNA | 42 | SGRNA | 34.15 |
20 | EVOLUTION | 42 | CANCER | 34.14 |